New Technology Solutions Use Real Time, Scientific, and Geocoded Data to `Flatten the COVID-19 Curve`
By HospiMedica International staff writers Posted on 01 Jun 2020 |
Illustration
Two new technology solutions will enable Americans to "Flatten the COVID-19 Curve" using real time, scientific, and geocoded data generated from social media, public, and private organizations.
The technology solutions have been developed by AEEC, LLC (Reston, VA, USA) in collaboration with Google Cloud. AEEC’s "Flatten the Curve" web application is a mobile application that will convey information for the public, health professionals, and policymakers in enhancing case detection, enabling digital contact tracing, and acting as a data capture portal for critical health data associated with COVID-19 and analyzed within Google Cloud Platform. It is built to deliver evidence-based public health interventions and inform the public about needed measures to avoid disease transmission.
AEEC’s Environmental Surface Sampling solution comprises a COVID-19 surface sampling process based on the company’s experience from 2001 Anthrax sampling across the US. AEEC has created a test platform for detecting the presence of viruses, such as COVID-19, using the methodology from the CDC's 2019-nCOV Real-Time RT-PCR Diagnostic protocol. The company’s solution assesses and determines the extent of surface contamination and provides an assurance for effective cleaning to eliminate presence of any COVID-19 at work locations or public areas. The test platform, including data storage, risk assessment results, data analytics, and chain of custody of samples are all managed in a secured Google Cloud environment.
Related Links:
AEEC, LLC
The technology solutions have been developed by AEEC, LLC (Reston, VA, USA) in collaboration with Google Cloud. AEEC’s "Flatten the Curve" web application is a mobile application that will convey information for the public, health professionals, and policymakers in enhancing case detection, enabling digital contact tracing, and acting as a data capture portal for critical health data associated with COVID-19 and analyzed within Google Cloud Platform. It is built to deliver evidence-based public health interventions and inform the public about needed measures to avoid disease transmission.
AEEC’s Environmental Surface Sampling solution comprises a COVID-19 surface sampling process based on the company’s experience from 2001 Anthrax sampling across the US. AEEC has created a test platform for detecting the presence of viruses, such as COVID-19, using the methodology from the CDC's 2019-nCOV Real-Time RT-PCR Diagnostic protocol. The company’s solution assesses and determines the extent of surface contamination and provides an assurance for effective cleaning to eliminate presence of any COVID-19 at work locations or public areas. The test platform, including data storage, risk assessment results, data analytics, and chain of custody of samples are all managed in a secured Google Cloud environment.
Related Links:
AEEC, LLC
Latest COVID-19 News
- Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles
- World's First Inhalable COVID-19 Vaccine Approved in China
- COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles
- Blood Viscosity Testing Can Predict Risk of Death in Hospitalized COVID-19 Patients
- ‘Covid Computer’ Uses AI to Detect COVID-19 from Chest CT Scans
- MRI Lung-Imaging Technique Shows Cause of Long-COVID Symptoms
- Chest CT Scans of COVID-19 Patients Could Help Distinguish Between SARS-CoV-2 Variants
- Specialized MRI Detects Lung Abnormalities in Non-Hospitalized Long COVID Patients
- AI Algorithm Identifies Hospitalized Patients at Highest Risk of Dying From COVID-19
- Sweat Sensor Detects Key Biomarkers That Provide Early Warning of COVID-19 and Flu
- Study Assesses Impact of COVID-19 on Ventilation/Perfusion Scintigraphy
- CT Imaging Study Finds Vaccination Reduces Risk of COVID-19 Associated Pulmonary Embolism
- Third Day in Hospital a ‘Tipping Point’ in Severity of COVID-19 Pneumonia
- Longer Interval Between COVID-19 Vaccines Generates Up to Nine Times as Many Antibodies
- AI Model for Monitoring COVID-19 Predicts Mortality Within First 30 Days of Admission
- AI Predicts COVID Prognosis at Near-Expert Level Based Off CT Scans